Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application Order of Locoid and Hylatopic Plus in Atopic Dermatitis
NCT02153762Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2013
- Primary completion
- Jan 2014
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of hydrocortisone butyrate and Hylatopic Plus in atopic dermatitis (AD), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Treatment Success at Day 29. Started Apr 2013; status: completed.
02
Drugs
hydrocortisone butyrateHylatopic Plus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02153762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153762.